TURNSTONE BIOLOGICS CORP.

Other languages Turnstone Biologics Corp.

Equities

TSBX

US90042W1009

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
2.66 ^USD	-2.56%		-12.79%	+4.52%

05-13	Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Turnstone Biologics Corp. Announces Board Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13
Turnstone Biologics Corp. Announces Board Changes	04-16
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-21
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer	02-20
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Top Premarket Gainers	11-03
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte Therapy in Solid Tumors At the 2023 Society for Immunotherapy of Cancer Annual Meeting	11-03
Insider Buy: Turnstone Biologics	23-07-27
Insider Buy: Turnstone Biologics	23-07-24
Turnstone Biologics Corp. has completed an IPO in the amount of $80.000004 million.	23-07-20
Turnstone Biologics Corp. has filed an IPO in the amount of $86.25 million.	23-06-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW